In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies.
Now, under RFK Jr., the agency is poised to reverse itself — despite the fact that few clinical studies support claims of the peptides’ effectiveness or safety.
https://www.propublica.org/article/peptide-safety-fda-compounding-pharmacies?utm_source=mastodon&utm_medium=social&utm_campaign=mastodon-post